Halothane enhances tonic neuronal inhibition by elevating intracellular calcium

Area of Science:

• Neuroscience
• Anesthesiology
• Molecular Pharmacology

Background:

• The precise mechanism by which anesthetics depress the central nervous system (CNS) is debated, with possibilities including reduced neuronal excitation or enhanced inhibition.
• Understanding anesthetic action is crucial for safe and effective clinical practice.

Purpose of the Study:

• To investigate the cellular mechanisms underlying the CNS depressant effects of halothane and pentobarbital.
• To determine whether anesthetic-induced CNS depression involves modulation of inhibitory neurotransmission, specifically via GABAA receptors.

Main Methods:

• Whole-cell patch-clamp recordings were performed on hippocampal slices to analyze spontaneous inhibitory postsynaptic currents (sIPSCs).
• The effects of halothane and pentobarbital on GABAA-mediated currents were assessed.
• Intracellular calcium dynamics were manipulated using BAPTA and dantrolene.
• The role of GABAA receptors was evaluated using the antagonist bicuculline.

Main Results:

• Both halothane and pentobarbital prolonged the decay time constant (TAU(D)) of GABAA-mediated sIPSCs, indicating enhanced inhibition.
• Halothane's effect was significantly attenuated by intracellular BAPTA or dantrolene, suggesting a role for intracellular calcium release.
• Pentobarbital's effect on sIPSCs was not altered by these calcium modulators.
• Halothane-induced depression of population spike amplitude was blocked by bicuculline, confirming GABAA receptor involvement.

Conclusions:

• A major depressant effect of halothane appears to be mediated by the enhancement of GABAA-ergic inhibition.
• This enhancement by halothane involves the release of intraneuronally stored calcium ions.
• Pentobarbital may exert its depressant effects through a different mechanism not dependent on intracellular calcium release.